Dr. Jack T. Stapleton, MD

Dr. Stapleton practices at University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa.

Dr. Stapleton's NPI, 1083603773, was assigned on October 17, 2005. Dr. Stapleton graduated from University of Kansas School of Med (KC/Wich/Sal) in 1980. Dr. Stapleton holds Iowa license 25543.

Dr. Stapleton's primary practice is University of Iowa Health Care Medical Center, at 200 Hawkins Drive, Iowa City, IA 52242 in Johnson County. The practice phone is (319) 356-1616.

Dr. Stapleton's primary practice is University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa. The medical group on file is Scanlan Center for School Mental Health Clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stapleton practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Stapleton's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Stapleton is licensed in Iowa.

CMS data shows 28 Medicare services from Dr. Stapleton across 1 procedure code in 2024, all of them office visits, for 30 Medicare patients. Medicare paid $1,085 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 30 Medicare patients who saw Dr. Stapleton in 2024. The largest group is 65 to 74, with 19 patients. 70% of them have high blood pressure, and 57% have high cholesterol. 50% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stapleton's median patient age at 66, with 18% women.

In 2024, Dr. Stapleton wrote 1,529 Medicare Part D claims for 50 patients. 69% of them were for generic drugs. CMS names the drug for 1,307 of them, across 57 drugs with 11 or more claims each, at $1,468,683 in total drug cost. In 2023, CMS named 1,003 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Stapleton for performance year 2024, reported as part of a group. Dr. Stapleton accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 97 papers to Dr. Stapleton, published from 2010 to 2025. 2017 was the busiest year, with 7. The most frequent topics are HIV Infections, Flaviviridae Infections and GB virus C. Dr. Stapleton has published most often in J Infect Dis. Dr. Stapleton's most frequent co-authors are Patricia Lee Winokur, MD, Mark J. Mulligan, MD and Nadine Georges Rouphael, MD.

Dmand AI links Dr. Stapleton to 1 clinical trial. Conditions studied include Smallpox and Poxviridae Infections.

CMS Open Payments shows 1 general payment to Dr. Stapleton from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $90.

Dr. Stapleton graduated from University of Kansas School of Med (KC/Wich/Sal) in 1980.